72 related articles for article (PubMed ID: 2989973)
1. Detection of hepatic metastases by proton spectroscopic imaging. Work in progress.
Lee JK; Heiken JP; Dixon WT
Radiology; 1985 Aug; 156(2):429-33. PubMed ID: 2989973
[TBL] [Abstract][Full Text] [Related]
2. Hepatic metastases studied with MR and CT.
Heiken JP; Lee JK; Glazer HS; Ling D
Radiology; 1985 Aug; 156(2):423-7. PubMed ID: 4011905
[TBL] [Abstract][Full Text] [Related]
3. Proton spectroscopic imaging (Dixon method) of the liver: clinical utility.
Schertz LD; Lee JK; Heiken JP; Molina PL; Totty WG
Radiology; 1989 Nov; 173(2):401-5. PubMed ID: 2552499
[TBL] [Abstract][Full Text] [Related]
4. Fatty infiltration of the liver: evaluation by proton spectroscopic imaging.
Heiken JP; Lee JK; Dixon WT
Radiology; 1985 Dec; 157(3):707-10. PubMed ID: 2997837
[TBL] [Abstract][Full Text] [Related]
5. Liver metastases: detection by phase-contrast MR imaging.
Stark DD; Wittenberg J; Middleton MS; Ferrucci JT
Radiology; 1986 Feb; 158(2):327-32. PubMed ID: 3941859
[TBL] [Abstract][Full Text] [Related]
6. Detection of hepatic metastases with MR imaging: spin-echo vs phase-contrast pulse sequences at 0.6 T.
Rummeny E; Saini S; Stark DD; Weissleder R; Compton CC; Ferrucci JT
AJR Am J Roentgenol; 1989 Dec; 153(6):1207-11. PubMed ID: 2683677
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of hepatic metastases from colorectal carcinoma with MR-superparamagnetic iron oxide.
Vidiri A; Carpanese L; Annibale MD; Caterino M; Cosimelli M; Zeuli M; David V; Crecco M
J Exp Clin Cancer Res; 2004 Mar; 23(1):53-60. PubMed ID: 15149151
[TBL] [Abstract][Full Text] [Related]
8. Dynamic MR imaging and early-phase helical CT for detecting small intrahepatic metastases of hepatocellular carcinoma.
Oi H; Murakami T; Kim T; Matsushita M; Kishimoto H; Nakamura H
AJR Am J Roentgenol; 1996 Feb; 166(2):369-74. PubMed ID: 8553950
[TBL] [Abstract][Full Text] [Related]
9. Optimal pulse sequence for imaging hepatic metastases.
Henkelman RM; Hardy P; Poon PY; Bronskill MJ
Radiology; 1986 Dec; 161(3):727-34. PubMed ID: 3786723
[TBL] [Abstract][Full Text] [Related]
10. Comparison between high-field-strength MR imaging and CT for screening of hepatic metastases: a receiver operating characteristic analysis.
Rummeny EJ; Wernecke K; Saini S; Vassallo P; Wiesmann W; Oestmann JW; Kivelitz D; Reers B; Reiser MF; Peters PE
Radiology; 1992 Mar; 182(3):879-86. PubMed ID: 1535912
[TBL] [Abstract][Full Text] [Related]
11. Whole-body MR imaging: evaluation of patients for metastases.
Lauenstein TC; Goehde SC; Herborn CU; Goyen M; Oberhoff C; Debatin JF; Ruehm SG; Barkhausen J
Radiology; 2004 Oct; 233(1):139-48. PubMed ID: 15317952
[TBL] [Abstract][Full Text] [Related]
12. Detection of hepatic metastases: comparison of contrast-enhanced CT, unenhanced MR imaging, and iron oxide-enhanced MR imaging.
Fretz CJ; Stark DD; Metz CE; Elizondo G; Weissleder R; Shen JH; Wittenberg J; Simeone J; Ferrucci JT
AJR Am J Roentgenol; 1990 Oct; 155(4):763-70. PubMed ID: 2119106
[TBL] [Abstract][Full Text] [Related]
13. Focal liver lesions: characterization with conventional spin-echo versus fast spin-echo T2-weighted MR imaging.
Schima W; Saini S; Echeverri JA; Hahn PF; Harisinghani M; Mueller PR
Radiology; 1997 Feb; 202(2):389-93. PubMed ID: 9015063
[TBL] [Abstract][Full Text] [Related]
14. Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging.
Dromain C; de Baere T; Lumbroso J; Caillet H; Laplanche A; Boige V; Ducreux M; Duvillard P; Elias D; Schlumberger M; Sigal R; Baudin E
J Clin Oncol; 2005 Jan; 23(1):70-8. PubMed ID: 15625361
[TBL] [Abstract][Full Text] [Related]
15. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
Low RN; Francis IR; Herfkens RJ; Jeffrey RB; Glazer GM; Foo TK; Shimakawa A; Pelc NJ
AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572
[TBL] [Abstract][Full Text] [Related]
16. MR imaging of hepatic metastasis in patients with malignant melanoma: evaluation of suspected lesions screened at contrast-enhanced CT.
Sofue K; Tateishi U; Tsurusaki M; Arai Y; Yamazaki N; Sugimura K
Eur J Radiol; 2012 Apr; 81(4):714-8. PubMed ID: 21353412
[TBL] [Abstract][Full Text] [Related]
17. MR imaging of hepatic metastases caused by neuroendocrine tumors: comparing four techniques.
Dromain C; de Baere T; Baudin E; Galline J; Ducreux M; Boige V; Duvillard P; Laplanche A; Caillet H; Lasser P; Schlumberger M; Sigal R
AJR Am J Roentgenol; 2003 Jan; 180(1):121-8. PubMed ID: 12490490
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma: MR imaging.
Itoh K; Nishimura K; Togashi K; Fujisawa I; Noma S; Minami S; Sagoh T; Nakano Y; Itoh H; Mori K
Radiology; 1987 Jul; 164(1):21-5. PubMed ID: 3035606
[TBL] [Abstract][Full Text] [Related]
19. Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy.
van Werven JR; Marsman HA; Nederveen AJ; Smits NJ; ten Kate FJ; van Gulik TM; Stoker J
Radiology; 2010 Jul; 256(1):159-68. PubMed ID: 20574093
[TBL] [Abstract][Full Text] [Related]
20. Focal malignant hepatic lesions: MR imaging enhanced with gadolinium benzyloxypropionictetra-acetate (BOPTA)--preliminary results of phase II clinical application.
Caudana R; Morana G; Pirovano GP; Nicoli N; Portuese A; Spinazzi A; Di Rito R; Pistolesi GF
Radiology; 1996 May; 199(2):513-20. PubMed ID: 8668804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
